Bank of America
TGTX icon

Bank of America’s TG Therapeutics TGTX Stock Holding History

Bank of America’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-150,000
Closed -$3.73M – 7947
2023
Q2 		$3.73M Buy
+150,000
New +$3.87M ﹤0.01% 3672
2020
Q1 		– Sell
-10,000
Closed -$111K – 7240
2019
Q4 		$111K Buy
+10,000
New +$76K ﹤0.01% 5952
2018
Q4 		– Sell
-667,100
Closed -$3.74M – 7379
2018
Q3 		$3.74M Buy
+667,100
New +$7.62M ﹤0.01% 3467

Other funds holding TGTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Bank of America's TGTX Position: Q1 2026 in Review

Bank of America increased its TG Therapeutics (TGTX) stake by 72% in Q1 2026, buying an estimated $18.2M and bringing the position to 1,461,302 shares worth $48.5M. The position accounts for ﹤0.01% of the portfolio, ranked #1614.

Bank of America first reported a position in TGTX in Q2 2013 and has held it in 51 quarters since. 363 funds tracked by Wall St. Rank hold TGTX as of Q1 2026.

  • Bank of America held 1,461,302 shares of TG Therapeutics worth $48.5M as of Q1 2026.
  • Bank of America bought 610,195 TG Therapeutics shares in Q1 2026, an estimated $18.2M.
  • TG Therapeutics made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #1614 holding.
  • Bank of America first reported a position in TG Therapeutics in Q2 2013 and has held it in 51 quarters since.
  • 363 funds tracked by Wall St. Rank held TG Therapeutics as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.